IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 32 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,018,000 | -20.6% | 949,000 | -20.3% | 0.00% | 0.0% |
| Q4 2020 | $1,282,000 | -29.9% | 1,190,000 | -32.7% | 0.00% | 0.0% |
| Q3 2020 | $1,830,000 | -1.1% | 1,769,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,851,000 | -0.6% | 1,769,000 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $1,862,000 | +399.2% | 1,769,000 | +405.4% | 0.00% | – |
| Q2 2019 | $373,000 | -83.3% | 350,000 | -82.8% | 0.00% | -100.0% |
| Q1 2019 | $2,232,000 | +145.0% | 2,030,000 | +108.2% | 0.00% | 0.0% |
| Q4 2018 | $911,000 | -64.0% | 975,000 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $2,531,000 | -2.1% | 1,950,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,585,000 | +1161.0% | 1,950,000 | +1014.3% | 0.00% | – |
| Q1 2018 | $205,000 | +144.0% | 175,000 | +136.5% | 0.00% | – |
| Q4 2016 | $84,000 | -4.5% | 74,000 | 0.0% | 0.00% | – |
| Q3 2016 | $88,000 | -94.3% | 74,000 | -95.1% | 0.00% | -100.0% |
| Q2 2016 | $1,547,000 | – | 1,511,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 2,000,000 | $2,676,000 | 4.66% |
| LINDEN ADVISORS LP | 61,156,000 | $82,021,000 | 3.46% |
| SSI INVESTMENT MANAGEMENT LLC | 9,719,000 | $13,007,000 | 1.15% |
| CSS LLC/IL | 15,280,000 | $20,475,000 | 0.99% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $10,070,000 | 0.92% |
| Castle Creek Arbitrage, LLC | 4,000,000 | $5,361,000 | 0.58% |
| DAFNA Capital Management LLC | 573,000 | $767,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 30,968,000 | $41,494,000 | 0.53% |
| Polar Asset Management Partners Inc. | 15,000,000 | $20,086,000 | 0.47% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,584,000 | $26,612,000 | 0.44% |